YU43499A - Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline - Google Patents
Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiselineInfo
- Publication number
- YU43499A YU43499A YU43499A YU43499A YU43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- sodium salt
- phenylpyrrolidin
- indole
- dichloro
- oxo
- Prior art date
Links
- 159000000000 sodium salts Chemical class 0.000 title abstract 2
- VDIRQCDDCGAGET-DHZHZOJOSA-N 4,6-dichloro-3-[(e)-(2-oxo-1-phenylpyrrolidin-3-ylidene)methyl]-1h-indole-2-carboxylic acid Chemical compound OC(=O)C=1NC2=CC(Cl)=CC(Cl)=C2C=1\C=C(C1=O)/CCN1C1=CC=CC=C1 VDIRQCDDCGAGET-DHZHZOJOSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU43499A true YU43499A (sh) | 2000-12-28 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU43499A YU43499A (sh) | 1997-03-05 | 1998-03-03 | Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (fr) |
| JP (1) | JP2001513796A (fr) |
| KR (1) | KR20000075907A (fr) |
| CN (1) | CN1249750A (fr) |
| AP (1) | AP9901637A0 (fr) |
| AR (1) | AR011178A1 (fr) |
| AU (1) | AU6825198A (fr) |
| BG (1) | BG103779A (fr) |
| BR (1) | BR9808305A (fr) |
| CA (1) | CA2282851A1 (fr) |
| CO (1) | CO4940415A1 (fr) |
| EA (1) | EA199900710A1 (fr) |
| EE (1) | EE9900387A (fr) |
| GB (1) | GB9704498D0 (fr) |
| HR (1) | HRP980114A2 (fr) |
| HU (1) | HUP0002109A2 (fr) |
| ID (1) | ID24207A (fr) |
| IL (1) | IL131489A0 (fr) |
| IS (1) | IS5166A (fr) |
| NO (1) | NO994303L (fr) |
| NZ (1) | NZ337315A (fr) |
| OA (1) | OA11154A (fr) |
| PE (1) | PE51399A1 (fr) |
| PL (1) | PL335652A1 (fr) |
| SK (1) | SK119699A3 (fr) |
| TR (1) | TR199902117T2 (fr) |
| WO (1) | WO1998039327A1 (fr) |
| YU (1) | YU43499A (fr) |
| ZA (1) | ZA981791B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX393950B (es) | 2017-06-12 | 2025-03-24 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/fr not_active Abandoned
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 EP EP98913613A patent/EP0966463A1/fr not_active Withdrawn
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/fr not_active Ceased
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000075907A (ko) | 2000-12-26 |
| CA2282851A1 (fr) | 1998-09-11 |
| GB9704498D0 (en) | 1997-04-23 |
| AP9901637A0 (en) | 1999-09-30 |
| HUP0002109A2 (hu) | 2001-04-28 |
| CO4940415A1 (es) | 2000-07-24 |
| NO994303L (no) | 1999-11-03 |
| IS5166A (is) | 1999-08-27 |
| ZA981791B (en) | 1999-09-03 |
| PL335652A1 (en) | 2000-05-08 |
| IL131489A0 (en) | 2001-01-28 |
| AU6825198A (en) | 1998-09-22 |
| NO994303D0 (no) | 1999-09-03 |
| HRP980114A2 (en) | 1998-12-31 |
| NZ337315A (en) | 2001-02-23 |
| EA199900710A1 (ru) | 2000-04-24 |
| BG103779A (en) | 2000-06-30 |
| JP2001513796A (ja) | 2001-09-04 |
| EP0966463A1 (fr) | 1999-12-29 |
| SK119699A3 (en) | 2000-05-16 |
| ID24207A (id) | 2000-07-13 |
| AR011178A1 (es) | 2000-08-02 |
| EE9900387A (et) | 2000-04-17 |
| PE51399A1 (es) | 1999-06-07 |
| BR9808305A (pt) | 2000-05-16 |
| TR199902117T2 (xx) | 2000-03-21 |
| WO1998039327A1 (fr) | 1998-09-11 |
| CN1249750A (zh) | 2000-04-05 |
| OA11154A (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| DE69418461D1 (de) | Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate | |
| EE9900217A (et) | Sulfiinhappe derivaadid, nende valmistamine ja kasutamine | |
| GR1001619B (el) | Παράγωγα ινδόλης. | |
| DK1177176T3 (da) | Triarylsyrederivater som PPAR-receptorligander | |
| YU49312B (sh) | Kristalni hidratni derivati 3,4,4-trisupstituisanih - peperidinil-n-alkilkarboksilata, njihovi intermedijari i postupak za dobijanje | |
| YU35697A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| DK0544819T3 (da) | Indolderivater, som inhiberer leukotrienbiosyntese | |
| TR200201668T2 (tr) | Vla-4' e bağlı hücre bağlamasının peptidilsiz önleyicileri | |
| BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
| TR199800436A2 (xx) | Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�. | |
| AU4831899A (en) | 5-HT1F agonists | |
| GB9514518D0 (en) | Guanidine salt inhibitors of NO synthase and cyclooxygenase | |
| MY123908A (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof | |
| AU2135695A (en) | Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
| YU43499A (sh) | Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline | |
| DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
| SE9802538D0 (sv) | New pharmaceutically active compounds | |
| AU562643B2 (en) | N-arylpiperazine derivatives | |
| PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
| TR200003570T2 (tr) | Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı |